CGC
Price
$1.34
Change
-$0.02 (-1.46%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
432.79M
42 days until earnings call
NBIX
Price
$140.97
Change
+$0.08 (+0.06%)
Updated
Sep 26, 04:37 PM (EDT)
Capitalization
13.97B
39 days until earnings call
Interact to see
Advertisement

CGC vs NBIX

Header iconCGC vs NBIX Comparison
Open Charts CGC vs NBIXBanner chart's image
Canopy Growth
Price$1.34
Change-$0.02 (-1.46%)
Volume$39.81K
Capitalization432.79M
Neurocrine Biosciences
Price$140.97
Change+$0.08 (+0.06%)
Volume$1K
Capitalization13.97B
CGC vs NBIX Comparison Chart in %
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. NBIX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a StrongBuy and NBIX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CGC: $1.37 vs. NBIX: $140.89)
Brand notoriety: CGC: Notable vs. NBIX: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 56% vs. NBIX: 118%
Market capitalization -- CGC: $432.79M vs. NBIX: $13.97B
CGC [@Pharmaceuticals: Generic] is valued at $432.79M. NBIX’s [@Pharmaceuticals: Generic] market capitalization is $13.97B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileNBIX’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • NBIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NBIX is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while NBIX’s TA Score has 3 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 5 bearish.
  • NBIX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CGC is a better buy in the short-term than NBIX.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а -0.72% price change this week, while NBIX (@Pharmaceuticals: Generic) price change was -3.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.63%. For the same industry, the average monthly price growth was +25.30%, and the average quarterly price growth was +68.14%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

NBIX is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.63% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($14B) has a higher market cap than CGC($433M). NBIX YTD gains are higher at: 3.216 vs. CGC (-50.000). NBIX has higher annual earnings (EBITDA): 557M vs. CGC (-410.31M). NBIX has more cash in the bank: 976M vs. CGC (144M). CGC has less debt than NBIX: CGC (328M) vs NBIX (439M). NBIX has higher revenues than CGC: NBIX (2.51B) vs CGC (275M).
CGCNBIXCGC / NBIX
Capitalization433M14B3%
EBITDA-410.31M557M-74%
Gain YTD-50.0003.216-1,555%
P/E RatioN/A41.68-
Revenue275M2.51B11%
Total Cash144M976M15%
Total Debt328M439M75%
FUNDAMENTALS RATINGS
CGC vs NBIX: Fundamental Ratings
CGC
NBIX
OUTLOOK RATING
1..100
6679
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9958
PRICE GROWTH RATING
1..100
5544
P/E GROWTH RATING
1..100
10027
SEASONALITY SCORE
1..100
1250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBIX's Valuation (75) in the Biotechnology industry is in the same range as CGC (93) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's SMR Rating (58) in the Biotechnology industry is somewhat better than the same rating for CGC (99) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew somewhat faster than CGC’s over the last 12 months.

NBIX's Price Growth Rating (44) in the Biotechnology industry is in the same range as CGC (55) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's P/E Growth Rating (27) in the Biotechnology industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCNBIX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
49%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
55%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 9 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TYO13.200.11
+0.88%
Direxion Daily 7-10 Yr Trs Bear 3X ETF
ICLO25.590.02
+0.10%
Invesco AAA CLO Floating Rate Note ETF
PCFI24.40N/A
N/A
POLEN FLOATING RATE INCOME ETF
PHO70.43-0.35
-0.50%
Invesco Water Resources ETF
YALL43.66-0.50
-1.13%
God Bless America ETF

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been loosely correlated with ACB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CGC jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-3.52%
ACB - CGC
65%
Loosely correlated
-4.44%
TLRY - CGC
61%
Loosely correlated
-5.56%
OGI - CGC
61%
Loosely correlated
-3.31%
CRON - CGC
57%
Loosely correlated
-2.58%
NBIX - CGC
31%
Poorly correlated
-3.94%
More

NBIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBIX has been loosely correlated with ELAN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NBIX jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
-3.94%
ELAN - NBIX
34%
Loosely correlated
+0.91%
LFCR - NBIX
32%
Poorly correlated
-3.47%
CGC - NBIX
31%
Poorly correlated
-3.52%
AQST - NBIX
31%
Poorly correlated
-2.95%
ALKS - NBIX
31%
Poorly correlated
-2.45%
More